[Elsevier] Comparative effectiveness of first-line targeted therapies in ALK-positive non-small cell lung cancer: real-world evidence of tyrosine kinase inhibitors

AhmadGGN Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-27 05:03
Reward20points

journalㄩLung Cancer

AuthorsㄩRahul Mudumba; Xiaofan Liu; Shihan Jin; Ian J. Davis; Drishti Baid; John A. Romley; Jorge J. Nieva

Published dateㄩ2026-7-

DOIㄩ10.1016/j.lungcan.2026.109451

PDF linkㄩhttps://www.sciencedirect.com/sc ... 16950022600512X/pdf

Article linkㄩhttps://doi.org/10.1016/j.lungcan.2026.109451

Article SourceㄩElsevier BV﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    50


Daily Top Contributors

Return to the list